Slideshow
Author(s):
Migraine is the second leading cause of disability worldwide. New data show the number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades.
Anthem Blue Cross Blue Shield Expands Policy Coverage to Include Nerivio Migraine Treatment
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
NeurologyLive® Friday 5 — May 2, 2025
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
From Sickle Cell to Stroke Prevention: Robert J. Adams’ Leadership in Brain Health Equity
Transforming Neurological Care Delivery: Barbara Vickrey’s SEQUINS Hall of Fame Journey